B-Cell Neoplasm — Trials

B-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–77 of 77 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04546893	Safety and Efficacy Study of SL1904B CAR-T Cells for Relapsed or Refractory B-Cell Acute Lymphocyte Leukemia	unknown	N/A	20	Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY	1	Sep 14, 2020	clinicaltrials
NCT04546906	Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia	unknown	N/A	20	Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY	1	Sep 14, 2020	clinicaltrials